Cargando…
Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?
Autores principales: | Cordie, Ahmed, El-Kotamy, Menna-t-allah, Esmat, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433226/ https://www.ncbi.nlm.nih.gov/pubmed/32832117 http://dx.doi.org/10.4102/sajhivmed.v21i1.1118 |
Ejemplares similares
-
COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?
por: Mohamed, Rahma, et al.
Publicado: (2020) -
Convergence of Mortality Rates among Patients on Antiretroviral Therapy in South Africa and North America
por: Binagwaho, Agnes, et al.
Publicado: (2014) -
Human immunodeficiency virus (HIV) and coronavirus disease 2019; impact on vulnerable populations and harnessing lessons learnt from HIV programmes
por: Cordie, A., et al.
Publicado: (2021) -
COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region
por: Mohamed, Rahma, et al.
Publicado: (2022) -
Eliminating hepatitis C from countries with high prevalence: When infrastructure comes first
por: Esmat, Gamal, et al.
Publicado: (2021)